Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0213520140280060460
Korean Journal of Ophthalmology
2014 Volume.28 No. 6 p.460 ~ p.465
Elevated Plasma Pentraxin 3 and Its Association with Retinal Vein Occlusion
Park Kyung-Soo

Kim Ji-Wan
An Jae-Hwan
Woo Je-Moon
Abstract
Purpose: To evaluate plasma pentraxin 3 (PTX3) in patients with retinal vein occlusion (RVO), and investigate the possibility of its role as a predictive biomarker.

Methods: Nested case-control study. The study included 57 patients with RVO and 45 age- and gender-matched subjects without RVO as controls. Plasma PTX3 and C-reactive protein concentration were measured in both groups a posteriori from frozen samples by using an enzyme-linked immunosorbent assay kit.

Results: The measured PTX3 value for the RVO group was 1,508 ¡¾ 1,183 pg/mL (mean ¡¾ standard deviation) and 833 ¡¾ 422 pg/mL for the controls (p < 0.001). There was no significant difference in PTX3 levels between patients with central retinal vein occlusion and branched retinal vein occlusion (1,468 ¡¾ 1,300 vs. 1,533 ¡¾ 1,121 pg/mL; p = 0.818).

Conclusions: Our data seems to support the role of chronic inflammation and ischemia in the development of RVO. It is possible that PTX3 can be used as a diagnostic biomarker of RVO.
KEYWORD
Biological markers, Inflammation, Ischemia, Pentraxin3, Retinal vein occlusion
FullTexts / Linksout information
 
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø